Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Orthopedic ClinicsReferences
- Prevalence and profile of high-impact chronic pain in the United States.J Pain. 2019; 20: 146-160
- Knee osteoarthritis has doubled in prevalence since the mid-20th century.Proc Natl Acad Sci U S A. 2017; 114: 9332-9336
- Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.Immunol Res. 2011; 49: 25-43
- Stem cells and platelet-rich plasma for knee osteoarthritis: prevalence and cost in South Florida.J Am Acad Orthop Surg. 2018; https://doi.org/10.5435/JAAOS-D-18-00343
- Platelets in wound healing and regenerative medicine.Platelets. 2018; 29: 556-568
- Regenerative medicine applications of mesenchymal stem cells.Adv Exp Med Biol. 2018; 1089: 115-141
- The current role of stem cells in orthopaedic surgery.Malays Orthop J. 2015; 9: 1-7
- The current perspectives of stem cell therapy in orthopedic surgery.Arch Trauma Res. 2016; 5: e37976
- Is stem cell therapy the future of orthopedics?.Knee Surg Relat Res. 2018; 30: 177-178
- Platelet-rich plasma: where are we now and where are we going?.Sports Health. 2010; 2: 203-210
- Clinical use of stem cells in orthopaedics.Eur Cell Mater. 2017; 33: 183-196
- The effect of intra-articular injection of autologous bone marrow stem cells on pain and knee function in patients with osteoarthritis.Int J Rheum Dis. 2018; 21: 140-147
- Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).J Transl Med. 2016; 14: 246
- Comparative clinical observation of arthroscopic microfracture in the presence and absence of a stromal vascular fraction injection for osteoarthritis.Stem Cells Transl Med. 2017; 6: 187-195
- Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis.J Transl Med. 2017; 15: 141
Available at: http://www.jrnlappliedresearch.com/articles/Vol11Iss1/Vol11%20Iss1Wei.pdf. Accessed March 4, 2019.
- A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis.Am J Sports Med. 2017; 45: 82-90
- The clinical evidence behind biologic therapies promoted at annual orthopaedic meetings: a systematic review.Arthroscopy. 2019; 35: 251-259
- Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells.Pain Physician. 2008; 11: 343-353
- Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial.Stem Cells Transl Med. 2016; 5: 847-856
- Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial.Stem Cells. 2014; 32: 1254-1266
- Arthroscopic transplantation of synovial stem cells improves clinical outcomes in knees with cartilage defects.Clin Orthop Relat Res. 2015; 473: 2316-2326
- Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis.Knee Surg Sports Traumatol Arthrosc. 2015; 23: 1308-1316
- Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial.Transplantation. 2015; 99: 1681-1690
- Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis.Knee. 2012; 19: 902-907
- Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study.J Bone Joint Surg Am. 2014; 96: 90-98
- Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up.Arthroscopy. 2013; 29: 2020-2028
- Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care.Pilot Feasibility Stud. 2018; 4: 93
- Clinical and MRI outcomes after platelet-rich plasma treatment for knee osteoarthritis.Clin J Sport Med. 2013; 23: 238-239
- Intra-articular platelet-rich plasma (PRP) injections for treating knee pain associated with osteoarthritis of the knee in the Japanese population: a phase I and IIa clinical trial.Nagoya J Med Sci. 2018; 80: 39-51
- Hyaluronic acid versus platelet-rich plasma: a prospective, double-blind randomized controlled trial comparing clinical outcomes and effects on intra-articular biology for the treatment of knee osteoarthritis.Am J Sports Med. 2017; 45: 339-346
- Knee osteoarthritis injection choices: platelet- rich plasma (PRP) versus hyaluronic acid (a one-year randomized clinical trial).Clin Med Insights Arthritis Musculoskelet Disord. 2015; 8: 1-8
- Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial.Am J Sports Med. 2013; 41: 356-364
- Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials.Arthroscopy. 2017; 33: 659-670.e1
- The temporal effect of platelet-rich plasma on pain and physical function in the treatment of knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials.J Orthop Surg Res. 2017; 12: 16
- From bench to FDA to bedside: US regulatory trends for new stem cell therapies.Adv Drug Deliv Rev. 2015; 82-83: 192-196
- FDA regulation of stem-cell-based therapies.N Engl J Med. 2006; 355: 1730-1735
- Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.J Clin Invest. 2011; 121: 3206-3219
- What Is the Price and Claimed Efficacy of Platelet-Rich Plasma Injections for the Treatment of Knee Osteoarthritis in the United States?.J Knee Surg. 2018; https://doi.org/10.1055/s-0038-1669953
- Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing.Ann Burns Fire Disasters. 2012; 25: 207-213
- The stem-cell market for the treatment of knee osteoarthritis: a patient perspective.J Knee Surg. 2018; 31: 551-556
Article info
Publication history
Footnotes
Disclosure Statement: One of the authors (C.J. Lavernia) certifies that he has or may receive royalty payments or benefits in an amount of USD 10,000 to USD 100,000 from Stryker (Mahwah, NJ, USA). He also owns stock in Johnson & Johnson (New Brunswick, NJ, USA), Zimmer (Warsaw, IN, USA), Stryker (Mahwah, NJ, USA), Wright (Arlington, TN, USA), and Symmetry Medical (Warsaw, IN, USA).
The authors have received financial support from Arthritis Surgery & Research Foundation for this article.